Thu, Dec 18, 2014, 6:38 AM EST - U.S. Markets open in 2 hrs 52 mins

Recent

% | $
Quotes you view appear here for quick access.

Cepheid Message Board

  • huntersmith1952 huntersmith1952 Feb 18, 2013 12:06 PM Flag

    Drug Resistant TB in India

    Interesting article in the weekend WSJ on drug resistant TB in India. Apparently WHO and and the medical profession are in disagreement on how India is handling its huge TB problem. The standard of care for drug resistant TB is still to offer the same 6 drug cocktail to which the TB is resistant. This seems to just perpetuate or amplify he drug resistance in TB. A survey indicated that 28% of Mumbai TB cases are drug resistant. India is also very slow to approve labs for detection of drug resistant TB (sounds like they have yet to fully embrace the Gene Xpert). India also appears to be downplaying its TB problem to keep its tourism, etc going.
    Unfortunately, it looks like CPHD will have a good market in India for years to come.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • There was an interesting piece this weekend entitled "HOTELS" on TV in which they highlighted India's obsession with the Marriott Hotel chain and others luring tourists to Mumbai. No mention, however, of the TB problem there, but there is plenty of "Graft" to get any kind of "permit" in India and it seems to be ingrained in their society that "bribes" are expected by the officials. How does an American based company do business in such an atmosphere of with "extortionist mentality"?...in fact, it was mentioned that one must bribe those in power positions to get even a parking place in Mumbai. How, then does a legitimate company like CPHD make headway in such a society for placement of its life-saving equipment without bribing???
      ...a different world out there...

 
CPHD
49.79+2.24(+4.71%)Dec 17 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.